一个氧化应激纳米放大器,用于改善瘤消除和联合免疫治疗
Wei Zhang1, Yijun Ran2, Mi Yang1
1Department of Ultrasound, Second Affiliated Hospital of Chongqing Medical University & Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing, 400010, China.
Advanced healthcare materials
|September 2, 2024
概括
这项研究介绍了PP@T,这是一种新的纳米放大器,可以放大氧化应激以杀死瘤细胞并减少转移. 这种图像引导系统增强了免疫疗法,用于精确的癌症治疗,副作用最小.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 瘤细胞死亡可以通过放大氧化应激来加速,破坏细胞内氧化还原稳定.
- 需要有针对性的疗法来增强瘤氧化,减少生长和转移.
研究的目的:
- 为增强瘤氧化疗法开发一种氧化应激放大器 (PP@T).
- 研究PP@T与免疫疗法结合的抗瘤和抗转移效应.
- 在体内治疗指导中使用光声学成像.
主要方法:
- 通过将MTH1抑制剂 (TH588) 嵌入PDA涂层PCN-224.4中来构建PP@T.
- 证明可以控制TH588的释放,以阻碍MTH1介导的DNA修复.
- 利用超声波辐射进行声动疗法,并诱导免疫细胞死亡.
- 在乳腺癌小鼠模型中评估了PP@T的疗效 (正位素和全身转移).
- 集成的光声成像用于体内监测.
主要成果:
- PP@T成功地放大了氧化应激,并加剧了DNA损伤.
- TH588释放通过防止8-oxo-dG水解来抑制MTH1的DNA修复功能.
- PP@T诱导了免疫细胞死亡,并触发了全身抗瘤免疫反应.
- 结合PP@T和免疫检查点阻塞阻碍了原发性瘤进展和转移.
- 光声学成像提供了有效的体内治疗指南.
结论:
- 开发的PP@T纳米系统有效地放大了用于瘤治疗的氧化应激.
- 图像引导PP@T与免疫疗法相结合显示出显著的抗瘤和抗转移潜力.
- 这种方法提供了一个精确而有效的策略来对抗具有微不足道副作用的瘤.
更多相关视频
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
15.9K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:46Electron Transport Chain: Complex I and II
12.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.3K